A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity
Clinical trial NCT06259981 · COMPLETED
Trial details
- NCT number
- NCT06259981
- Sponsor
- Glyscend, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-20
- Primary completion
- 2024-10-23
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.